Cargando…
Abatacept in psoriatic arthritis: Case report and short review
Psoriatic arthritis (PsA) is a chronic inflammatory disease affecting about 6-10% of patients with cutaneous psoriasis. According to current knowledge, activated T-cells seem to play a pivotal role in the pathogenesis of both psoriasis and PsA. Abatacept is a novel biologic agent selectively designe...
Autores principales: | Ursini, Francesco, Naty, Saverio, Russo, Emilio, Grembiale, Rosa Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853664/ https://www.ncbi.nlm.nih.gov/pubmed/24347977 http://dx.doi.org/10.4103/0976-500X.120943 |
Ejemplares similares
-
Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis: An Observational Study
por: Ursini, Francesco, et al.
Publicado: (2015) -
Current treatment options for psoriatic arthritis: spotlight on abatacept
por: Ursini, Francesco, et al.
Publicado: (2018) -
Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis
por: Ursini, Francesco, et al.
Publicado: (2016) -
Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy
por: Ursini, Francesco, et al.
Publicado: (2015) -
Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis
por: Patanè, Marinella, et al.
Publicado: (2013)